|
Project detail:
As per EIA Notification (S.O. 1533) dated 14th September, 2006, the project is to be appraised by the MOEF&CC, New Delhi as per the provisions of the EIA notification & its subsequent amendments the project falls at Serial no. ‘5(f)’ activity under its subsequent amendments the project falls at Serial no. ‘5(f)’ activity under synthetic organic chemical industry (dyes & dye intermediates; bulk drugs and intermediates excluding drug formulations; synthetic rubbers; basic organic chemicals, other synthetic organic chemicals and chemical intermediates). Due to applicability of General Conditions it is Category ‘A’ project, as the Interstate Boundary of Punjab and Haryana falls at a distance of 0.72 Km radius from the project site. Thus, Satisfying the general condition, the case will be appraised at Central Level by MOEF&CC New Delhi.
The growth of industries in the area will generate the employment as well as the development of the area. Another major aspect of industrial growth is the emergence of the middle class. In the pre-industrial era, society was divided between wealthy people and workers (mostly agriculture). However, industrialization led to the concept of monthly wages and a new working class "The middle class". Workers are no longer dependent on the weather and seasons for their livelihood.
According to IMF world Economic Outlook Update (January 2017), Indian economy has grown over7.2% during FY2017and further accelerate to 7.7% during FY2018.Corporate earnings in India are expected to grow by over 20 % in FY 2018. Considering the anticipated demand of health care sector in the domestic as well as the global market and the growing volume of pharma industry, the proposed project to manufacture pharma sector bulk drugs and drugs intermediates have no doubts for its acceptability in the domestic and international market.
Project Cost: Rs 15.65 Crores
Note: please download project document attached to this project for more information.
|
